Phase I study of single-agent CC-292, a highly selective Bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Published Web Location

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Editorial: Neurocardiology: the science of heart–brain interactions
- Tomar, Shubham;
- Lidani, Karita Claudia Freitas;
- Mallugari, Ravinder;
- Longardner, Katherine;
- Venugopal, Bhavya Jaya
AI-Informed 30-Day MACE Risk Predictions in ED Arrivals
- Gross, Ben J;
- Patel, MD Radha;
- Zheng, Kai;
- Nemati, Shamim;
- Ramsis, MD Mattheus
Modeling the impact of changing drug markets and structural determinants on HCV and/or HIV transmission among people who inject drugs in the United States: A rural and urban comparison
- Martin, Natasha K;
- Abramovitz, Daniela;
- Eger, William H;
- Friedman, Joseph R;
- Borquez, Annick;
- Cheema, Jaskaran S;
- Stamos-Beusig, Tara;
- Stone, Jack;
- Vickerman, Peter;
- Bradley, Heather;
- Westergaard, Ryan P;
- Strathdee, Steffanie A
Targeting PRDX1 impairs acute myeloid leukemic blasts and stem cells by disrupting redox homeostasis
- Li, Zhenghao;
- Liu, Guangci;
- Chen, Ziren;
- Li, Keming;
- Yu, Zhe;
- He, Chao;
- Ying, Xinyu;
- Huang, Danling;
- Tao, Chengtian;
- Khan, Sajid;
- Wang, Yimeng;
- Zhang, Fang-Lin;
- Li, Huan;
- Chen, Yun;
- Zhou, Jingfeng;
- Yu, Li;
- Kipps, Thomas J;
- Cheng, Yongxian;
- Zhang, Suping
A scholar of blood and beauty: remembering Prof. Jacques-Louis Binet (1932–2024)
- Kipps, Thomas J